News & Media
Social Media
The below stream is intended to provide information and content about our US business.
-
@BOEHRINGERUS 18 Apr 2018 at 12:00
-
BOEHRINGER INGELHEIM
18 Apr 2018 at 10:00Meet BI employee Sammy Bell of Duluth, GA and see how, in volunteering with American Chemical... -
@BOEHRINGERUS 18 Apr 2018 at 06:03
We have strong roots in the #Boston #Biotech community. This is why we’re hosting our next Office Hours on May 10. There are still open slots so sign up today for our free mentoring program: http://bit.ly/2GVSdNX
-
BOEHRINGER INGELHEIM
17 Apr 2018 at 16:00Want to know more about #scleroderma? Learn about this #raredisease here: http://bit.ly/2Hui6I8 ... -
@BOEHRINGERUS 17 Apr 2018 at 13:00
We’re exploring the effects of our #T2D treatment in adults w/ chronic #kidneydisease. Learn more: http://bit.ly/2H5ZKdk
-
@BOEHRINGERUS 17 Apr 2018 at 11:30
Emily Corse, Ph.D., has joined our team to further solidify our leadership in the science of #cancer immunology therapies
-
@BOEHRINGERUS 17 Apr 2018 at 08:00
#NEWS: The @US_FDA has provided full approval for our specific #OAC reversal agent. Learn more here: http://bit.ly/2H72WcG
-
@BOEHRINGERUS 16 Apr 2018 at 12:00
It only took one phone call leading to a #biotech collaboration that holds the potential to re-imagine #cancer immunotherapies. Read more about our unique partnership with AbeXXa Biologics: http://bit.ly/2GVdVG4
-
@BOEHRINGERUS 16 Apr 2018 at 07:41
We and @LillyDiabetes are partnering w/ @UniofOxford & @DCRINews to study the effects of our #T2D treatment in adults w/ chronic #kidneydisease
-
@BOEHRINGERUS 13 Apr 2018 at 13:19
We are in #Chicago for the #AACR Annual Meeting April 14-18. Driving Innovative #Cancer Science to Patient care. Come visit our booth #2908 to learn about our exciting job openings in Cancer Immunology. http://bit.ly/2EJGoIP
-
BOEHRINGER INGELHEIM
13 Apr 2018 at 12:10Join us in Miami at Hispanicize ‘18! We’re excited to present the “Let’s Learn Together With Don... -
@BOEHRINGERUS 13 Apr 2018 at 11:00
Join us in Miami at #Hispz18! We’re excited to present the “Let’s Learn Together With Don Francisco; Understanding the Facts About Type 2 Diabetes” panel w/@LillyDiabetes and @DonFranciscoTV.
-
@BOEHRINGERUS 05 Apr 2018 at 10:00
We are pleased to host another BI office Hours on May 10. Sign up for your opportunity to sit down and chat with our leadership about your big idea: http://bit.ly/2GYemys http://bit.ly/2H9Wr5H
-
@BOEHRINGERUS 04 Apr 2018 at 11:05
We are proud to announce our exclusive partnership with @OSEIMMUNO. Together we are working to develop a novel treatment option for cancer patients! http://bit.ly/2EhkmNq #Biotechnology #Oncology #ImmunoOncology
-
BOEHRINGER INGELHEIM
04 Apr 2018 at 08:46Our #BreathlessIPF campaign is hitting it out of the park – again! This year we’re teaming up... -
@BOEHRINGERUS 29 Mar 2018 at 09:30
We just released new data comparing two of our medicines in reducing the risk of COPD flare-ups. Learn more here: http://bit.ly/2uvCeo0
-
BOEHRINGER INGELHEIM
28 Mar 2018 at 16:00Get your peanuts and Cracker Jacks ready because we just announced that we’re teaming up with... -
BOEHRINGER INGELHEIM
28 Mar 2018 at 12:31Our Chief Diversity Officer Nancy Di Dia shares her three pieces of advice for female... -
BOEHRINGER INGELHEIM
27 Mar 2018 at 16:00Take us out to the ball game! It’s baseball season, and we’re preparing to blow you away with our... -
BOEHRINGER INGELHEIM
27 Mar 2018 at 12:30As part of our month-long celebration of Women’s History Month, we’d like to introduce our social...